Yaz, Yasmin, BeYaz and Ocella increase the risk of pulmonary embolism by 74%
Yaz and Yasmin were ranked second highest in 2011 for the number of complications reported to the FDA, (Food and Drug Administration) according to the QuarterWatch report from the Institute for Safe Medicine Practices.
Bayer, the manufacturer of Yaz and Yasmin has started settling some injury claims due to the use of Yaz and Yasmin at an average of $212,000 per case.
The Yaz Resource Center (a patient advocacy group) has been alerting women with questions about Yaz that the birth control drug has been linked to blood clot injuries.
Anyone affected by pulmonary embolism, blood clots, DVT or stroke after taking Yaz, Yasmin, BeYaz, or Ocella should contact a Multi-district Litigation Lawyer (MDL) who handles Yaz cases.
To contact a MDL attorney that represents women who have been harmed by Yaz, Yasmin, BeYaz or Ocella either fill out the form to your right, or visit our site at The Maher Law Firm